US Patent 11364302 Nucleic acid-polypeptide compositions and uses thereof
Patent 11364302 was granted and assigned to Avidity Biosciences on June, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Andrew John Geall0
Barbora Malecova0
David Sai-Ho Chu0
Joel Daniel Arias0
Michael Caramian Cochran0
Philip Kovach0
Rob Burke0
Venkata Ramana Doppalapudi0
Edits on 1 Apr, 2023
Golden AI
Infobox
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113643020
Date of Patent
June 21, 2022
0Patent Application Number
173647540
Date Filed
June 30, 2021
0Patent Citations
Patent Primary Examiner
Edits on 22 Jun, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+367 characters)
US Patent 11364302 Nucleic acid-polypeptide compositions and uses thereof
Article
Disclosed herein are compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a modified polynucleic acid molecule and a polymer. Also described herein include methods for treating a cancer which utilize a composition or a pharmaceutical formulation comprising a binding moiety conjugated to a polynucleic acid molecule and a polymer.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11364302
Date of patent
June 21, 2022
Patent application number
17364754
Date Filed
June 30, 2021
Patent citations
Patent primary examiner
Find more entities like US Patent 11364302 Nucleic acid-polypeptide compositions and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
